The Bulletin
The Times


.

Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval

  • Written by PR Newswire

SHENZHEN, China, July 31, 2024 /PRNewswire/ -- On July 28 2024, Kexing Biopharm announced European Commission approval of Apexelsin®, the generic drug to Bristol Myers Squibb's and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed by WhiteOak Pharmaceutical B.V. and Kexing Biopharm is in charge of the commercialization of...

The Bulletin Magazine

Why Inspector Selection is the Most Critical Step in a Property Purchase

Don’t Let the Bed Bugs Bite… Tips for Getting Rid of Bed Bugs

The Cost of Oversight: Immediate Signs The Last Bathroom Reno Wasn’t Done Right

Towing Considerations for Pop Top Caravans

Why Choosing The Right Rims And Tyres For Sale in Sydney Matters For Vehicle Performance

Why Roller Shutters Continue Growing In Demand Across Melbourne

How Mining Hoses Support Safe And Efficient Fluid Transfer In Heavy-Duty Operations

Why Choosing The Right Dentist Impacts Your Long-Term Oral Health

Making Saving Money More Engaging for Children

Dental Emergencies in Sydney: What To Do Before You Reach the Clinic

Why Visiting A Lighting Shop in Perth Can Can Improve Homeowners' Trust in Interior Design

Why Safety Certified I/O Module Is Critical For Industrial Automation Systems

hacklink hack forum hacklink film izle hacklink grandpashabetgrandpashabetz library frDeneme bonusu veren siteler 2026Deneme bonusu veren siteler 2026Grandpashabetmarsbahis girişbahiscasinobetparkaresbetmarsbahisbahiscasinograndpashabettarafbetbetasus girişjojobetcasibomholiganbetcasibommeritkingjojobetcasibomjojobetcratosroyalbetdeneme bonusugrandpashabetpusulabet